This special quarterly report for both the Global Healthcare Council and Global AI Council picks up how developments in one field are increasingly relevant for others.
May 2022 issue editorial by James Mawson, editor-in-chief, Global Corporate Venturing
GCV Powerlist 2022 editorial by James Mawson, editor in chief, Global Corporate Venturing
Global Energy Council Q2 2022 editorial by James Mawson, editor in chief, Global Corporate Venturing
April 2022 editorial by James Mawson, editor-in-chief, Global Corporate Venturing
Oncology Q1 2022 editorial by James Mawson, editor in chief, Global Corporate Venturing
GCV Mobility Q1 2022 supplement editorial by James Mawson, editor in chief, Global Corporate Venturing
March 2022 editorial by James Mawson, editor-in-chief, Global Corporate Venturing
The corporate venturing industry is pushing towards a 50:50 split in senior investor roles.
Industry Q1 2022 editorial by James Mawson, editor in chief, Global Corporate Venturing
A decade's focus on digitalisation leaves physical assets vulnerable.
February 2022 editorial by James Mawson, editor-in-chief, Global Corporate Venturing
James Mawson reviews the current issues in the annual Rising Stars countdown
The corporate venturing industry is pushing towards a 50:50 split in senior investor roles.
A decade's focus on digitalisation leaves physical assets vulnerable.
In the first part of our look at 2021's corporate venturing trends, we examine the growth in funding, IPOs and SPAC mergers, a big year for M&A and the emergence of CVC in new sectors.
GEC Healthcare Q1 2021 forward by Rob Coppedge, chief executive, Echo Health Ventures, and Bill Taranto, and president, Merck Global Health Innovation Fund
Global Corporate Venturing (GCV) is where global innovation and capital converge to define, invest and shape the world of tomorrow. We provide the world’s investors and the wider innovation ecosystem with the information, insights, collaboration and access they need to succeed in a constantly changing world.
